Based on these findings, the most logical explanation is that the amyloid lesions detected in the brains of CJD patients who had previously received hGH therapy were propagated and generated by hGH extract preparations contaminated with aggregating amyloid-β nuclei [71]. This evidence concerns the gene GH1 and Creutzfeldt Jacob disease.